keyword
Keywords screening programs for cervica...

screening programs for cervical cancer

https://read.qxmd.com/read/38381754/interventions-to-increase-follow-up-of-abnormal-cervical-cancer-screening-results-a-systematic-literature-review-and-meta-analysis
#21
JOURNAL ARTICLE
Melissa Lopez Varon, Yimin Geng, Bryan M Fellman, Catherine Troisi, Maria E Fernandez, Ruosha Li, Belinda Reininger, Kathleen M Schmeler, Emma Allanson
INTRODUCTION: Ensuring timely follow-up of abnormal screening results is essential for eliminating cervical cancer. OBJECTIVE: The purpose of the study was to review single and multicomponent interventions designed to improve follow-up of women with abnormal cervical cancer screening results. We report on effectiveness across studies, and describe what aspects of these interventions might be more impactful. METHODS: Publications were searched between January 2000 and December 2022...
2024: PloS One
https://read.qxmd.com/read/38380669/-escherichia-coli-and-hpv16-coinfection-may-contribute-to-the-development-of-cervical-cancer
#22
JOURNAL ARTICLE
Qin Zou, Yingying Wu, ShuaiShuai Zhang, Shu Li, Siyue Li, Yan Su, Lei Zhang, Qian Li, Hua Zou, Xinyuan Zhang, Teng Wang, Shuang Liang, Jun Yang, Chunli Li
Persistent human papillomavirus HPV infection is a necessary but insufficient condition for cervical cancer. Microorganisms are crucial environmental factors in cancers susceptibility and progression, recently attracting considerable attention. This study aimed to determine the infection status and relationship between high-risk HPV (HR-HPV) and lower genital tract infectious pathogens in cervical cancer and its precursors. From a retrospective and a prospective cohort analysis, Escherichia coli ( E. coli ) dominated the pathogens isolated from cervical discharges, and an isolation rate uptrend has been shown recently...
December 2024: Virulence
https://read.qxmd.com/read/38373946/knowledge-regarding-human-papillomavirus-and-cervical-cancer-prevention-among-medical-students-from-chulalongkorn-university-in-thailand
#23
JOURNAL ARTICLE
Monchada Sukrong, Peerapong Prapaisilp, Tunchanok Juntamongkol, Noppachai Siranart, Natacha Phoolcharoen, Nicha Assavapokee, Nakarin Sirisabya, Somsook Santibenchakul
BACKGROUND: Cervical cancer is one of the leading causes of death among women in Thailand. General practitioners, within their primary healthcare role, play a vital role in the cervical cancer screening program, as they are the healthcare professionals most easily accessible to the general population. This study aims to determine the level of knowledge of cervical cancer and human papillomavirus (HPV) infection, HPV vaccination, and cervical cancer screening among last-year medical students...
February 19, 2024: BMC Women's Health
https://read.qxmd.com/read/38371106/knowledge-and-attitude-of-parents-regarding-the-human-papillomavirus-vaccine-as-a-new-component-in-the-saudi-vaccination-schedule
#24
JOURNAL ARTICLE
Abdulrahman A Bin Alamir, Abdullah H Almotairi, Fahad H Almutairi, Khaled N Almujel, Abdalah E Almhmd, Abdulrahman F Alanazi, Khalid F Alotaibi, Mohammed H Alanazi, Amer S Alsaeri, Meshal A Alruwaili, Rayan S Alghamdi
Background The most frequent gynecologic cancer in women is cervical cancer. The majority of incidents take place in less developed nations without access to reliable screening tools. Human papillomavirus (HPV) exposure, smoking, and immune system dysfunction are risk factors. As a result of effective screening, its incidence and death have significantly decreased in many nations. Hence, this study aims to assess the level of knowledge and awareness among parents regarding HPV, including its associated health risks and the benefits of vaccination...
January 2024: Curēus
https://read.qxmd.com/read/38370982/barriers-to-and-facilitators-of-screening-for-cervical-and-breast-cancer-experiences-of-non-adherent-women-with-current-or-previous-drug-use
#25
JOURNAL ARTICLE
Lars Garpenhag, Disa Dahlman
OBJECTIVE: Women with current or previous drug use (WCPDU) have an increased risk of poor cervical and breast cancer outcomes, and low participation in screening for these cancer forms. The aim of this study was to assess self-reported barriers to and facilitators of cervical and breast cancer screening, among WCPDU. METHODS: A survey based on results from a previous qualitative study about WCPDUs experiences of cancer screening was distributed to WCPDU at six opioid agonist treatment (OAT) clinics and one needle exchange program (NEP) in Malmö, Sweden, and through the Drug Users Union in Stockholm, Sweden...
March 2024: Preventive Medicine Reports
https://read.qxmd.com/read/38368574/performance-of-urine-samples-compared-to-cervical-samples-for-detection-of-precancer-lesions-among-hpv-positive-women-attending-colposcopy-clinic-in-mexico-city
#26
JOURNAL ARTICLE
Joacim Meneses-León, Sonia Hernández-Salazar, Leticia Torres-Ibarra, Rubí Hernández-López, Berenice Rivera-Paredez, Karina Robles-Rivera, Eduardo Lazcano-Ponce, Alba García-Vera, Mélany Godínez-Pérez, Leith León-Maldonado, Jorge Salmerón
BACKGROUND: High-risk human papillomavirus (hrHPV) detection in self-collected urine samples (SeCUS) may be a promising alternative for cervical cancer screening because of its greater acceptability, as long as it can offer comparable sensitivity to clinician-collected cervical samples (CCoS) for detecting precancer lesions. OBJECTIVE: To evaluate the performance of the SeCUS compared to that of the CCoS for cervical intraepithelial neoplasia grade 3 (CIN3) detection among hrHPV-positive women receiving colposcopy in Mexico City using different specific extended HPV typing procedures: HPV16/18, HPV16/18/35/39/68 or HPV16/18/35/39/68/31...
February 18, 2024: Cancer Causes & Control: CCC
https://read.qxmd.com/read/38365690/cervical-cancer-screening-program-in-indonesia-is-it-time-for-hpv-dna-tests-results-of-a-qualitative-study-exploring-the-stakeholders-perspectives
#27
JOURNAL ARTICLE
Fitriana Murriya Ekawati, Putri Listiani, Sri Idaiani, Jarir At Thobari, Firdaus Hafidz
OBJECTIVES: Cervical cancer is a significant public health concern in Indonesia, and effective screening methods are necessary to improve the detection and reduce mortality. This study aimed to explore the perspectives of high-level stakeholders involved in cervical cancer screening in Indonesia and whether the use of human papillomavirus-deoxyribonucleic acid (HPV-DNA) methods for cervical cancer screening is acceptable in Indonesian settings. METHODS: A qualitative research approach guided by realist evaluation was applied using focus group discussions (FGDs) between December 2021 and February 2022, conducted with stakeholders involved in cervical cancer screening in Indonesia...
February 16, 2024: BMC Women's Health
https://read.qxmd.com/read/38359369/real-world-cervical-cancer-screening-uptake-and-predictors-of-visual-inspection-with-acetic-acid-positivity-among-women-living-with-hiv-in-care-programs-in-western-kenya
#28
JOURNAL ARTICLE
Chemtai Mungo, Omenge Orang'o, Susan Ofner, Beverly Musick, Constantin Yiannoutsos, Craig R Cohen, Darron Brown, Kara Wools-Kaloustian, Aggrey Semeere
PURPOSE: To achieve the WHO cervical cancer elimination targets, countries globally must achieve 70% cervical cancer screening (CCS) coverage. We evaluated CCS uptake and predictors of screening positive at two public HIV care programs in western Kenya. METHODS: From October 2007 to February 2019, data from the Family AIDS Care and Education Services (FACES) and Academic Model Providing Access to Healthcare (AMPATH) programs in western Kenya were analyzed. The study population included women age 18-65 years enrolled in HIV care...
February 2024: JCO global oncology
https://read.qxmd.com/read/38352226/toward-ovarian-cancer-screening-with-protein-biomarkers-using-dried-self-sampled-cervico-vaginal-fluid
#29
JOURNAL ARTICLE
Julia Hedlund Lindberg, Anna Widgren, Emma Ivansson, Inger Gustavsson, Karin Stålberg, Ulf Gyllensten, Karin Sundfeldt, Jonas Bergquist, Stefan Enroth
Early detection is key for increased survival in ovarian cancer, but no general screening program exists today due to lack of biomarkers and overall cost versus benefit over traditional clinical methods. Here, we used dried cervico-vaginal fluid (CVF) as sampling matrix coupled with mass spectrometry for detection of protein biomarkers. We find that self-collected CVF on paper cards yields robust results and is suitable for high-throughput proteomics. Artificial intelligence-based methods were used to identify an 11-protein panel that separates cases from controls...
February 16, 2024: IScience
https://read.qxmd.com/read/38347497/factors-associated-with-utilization-of-cervical-cancer-screening-services-among-hiv-positive-women-aged-18-to-49-years-at-lira-regional-referral-hospital-northern-uganda
#30
JOURNAL ARTICLE
Florence Layet, Tom Murungi, Nasser Ashaba, Eustes Kigongo, Marc Sam Opollo
BACKGROUND: Women with HIV have a higher risk of getting cervical cancer due to induced immunosuppression. Though this burden could be avoided through early identification and appropriate management, there is a paucity of information about the utilization of cervical cancer screening (CCS) services in Lira City, Uganda. This study investigated the level and factors associated with the utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira Regional Referral Hospital, Lira City, Uganda...
February 12, 2024: BMC Women's Health
https://read.qxmd.com/read/38332935/cervical-cancer-screening-coverage-in-the-americas-region-a-synthetic-analysis
#31
JOURNAL ARTICLE
Ginna Fernández-Deaza, Beatriz Serrano, Esther Roura, Juan Sebastián Castillo, María Caicedo-Martínez, Laia Bruni, Raúl Murillo
BACKGROUND: The Americas region has the lowest (North America) and the second highest (Latin America and Caribbean) cervical cancer (CC) mortality worldwide. The lack of reliable data on screening coverage in the region hinders proper monitoring of the World Health Organization (WHO) CC elimination initiative. METHODS: For this synthetic analysis, we searched data on CC screening coverage from official sources and national health surveys, supplemented with a formal WHO country consultation...
February 2024: Lancet Reg Health Am
https://read.qxmd.com/read/38325609/cervical-cancer-screening-activity-in-the-capital-region-of-denmark-before-during-and-after-the-covid-19-pandemic
#32
JOURNAL ARTICLE
Birgitte Tønnes Pedersen, Helle Pedersen, Reza Serizawa, Si Brask Sonne, Emilie Korsgaard Andreasen, Jesper Bonde
OBJECTIVE: Denmark went through various COVID-19 pandemic restrictions including periodic lockdowns from March 2020 to January 2022. All cancer screening programs were kept operational, yet access to clinicians for cervical screening was at times limited. We assessed the impact of the pandemic on cervical cancer screening activity in the Capital Region of Denmark. METHODS: Cervical screening activity was defined as regular screening by invitation, opportunistic screening, and screening participation by HPV self-sampling...
March 2024: Preventive Medicine
https://read.qxmd.com/read/38323823/performance-of-bd-onclarity-hpv-assay-on-floqswabs-vaginal-self-samples
#33
JOURNAL ARTICLE
Marianna Martinelli, Ardashel Latsuzbaia, Jesper Bonde, Helle Pedersen, Anna D Iacobone, Fabio Bottari, Andrea F Piana, Roberto Pietri, Clementina E Cocuzza, Marc Arbyn
This study assessed the accuracy of high-risk human papillomavirus testing of BD Onclarity HPV (Onclarity) assay on vaginal self-collected FLOQSwab versus cervical samples to ensure similar accuracy to detect cervical intraepithelial neoplasia. Testing was performed on two automated platforms, BD Viper LT and BD COR, to evaluate the effect of machine and using two vaginal self-samples to analyze the influence of collection, transport, and freezing-unfreezing on the results. A cervical sample and two self-samples were collected from 300 women...
February 7, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38321465/exploring-self-care-and-cervical-cancer-prevention-attitudes-and-practices-among-moroccan-and-pakistani-immigrant-women-in-catalonia-spain-a-comparative-qualitative-study
#34
JOURNAL ARTICLE
Jone G Lurgain, Hakima Ouaarab-Essadek, Khadija Mellouki, Sumaira Malik-Hameed, Andleeb Sharif, Maria Brotons, Laia Bruni, Paula Peremiquel-Trillas
BACKGROUND: Self-care and preventive health strategies may trigger health inequities when individuals' cultural values and health beliefs are not fully understood and considered. In the case of cervical cancer (CC) screening programs immigrant women have shown lower attendance compared with native women, which increases the risk of late diagnosis and, consequently, a lower probability of survival. HPV self-sampling for CC screening has been recently added to the World Health Organization's (WHO) list of self-care interventions as a promising tool to reduce this disparity and improve screening coverage...
February 6, 2024: BMC Public Health
https://read.qxmd.com/read/38306594/risk-of-cervical-abnormalities-for-women-with-multiple-sclerosis-treated-with-moderate-efficacy-and-high-efficacy-disease-modifying-therapies
#35
MULTICENTER STUDY
Francesca Bridge, Julia Brotherton, Jim Stankovich, Paul G Sanfilippo, Olga G Skibina, Katherine Buzzard, Tomas Kalincik, Ai-Lan Nguyen, Kylie Guo, Mastura Monif, C David Wrede, Louise Rath, Lisa Taylor, Helmut Butzkueven, Vilija G Jokubaitis, Anneke Van Der Walt
BACKGROUND AND OBJECTIVES: The impact of immunomodulatory therapies on the risk of cervical pre-cancer and invasive cancer development is important for the health and safety of women with multiple sclerosis (wwMS). We investigate the risk of cervical abnormalities in wwMS treated with disease-modifying therapies (DMTs). METHODS: This is a multicenter cohort study with data collected from 1998 to 2019 in Victoria, Australia. Data linkage was performed using matching records from the MSBase Registry, the National Human Papillomavirus (HPV) Vaccination Program Register, and the Victorian Cervical Cytology Register...
February 2024: Neurology
https://read.qxmd.com/read/38301312/variation-in-cervical-cancer-screening-test-utilization-and-results-in-a-united-states-based-program
#36
JOURNAL ARTICLE
Vanessa G Dorismond, Mona Saraiya, Sameer V Gopalani, Ashwini Soman, Kristy Kenney, Jacqueline Miller, George F Sawaya
BACKGROUND: Little is known about cervical cancer screening strategy utilization (cytology alone, cytology plus high-risk human papillomavirus [HPV] testing [cotesting], primary HPV testing) and test results in the United States. METHODS: Data from the Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program were analyzed for 199,578 persons aged 21-65 years screened from 2019 to 2020. Screening test utilization and results were stratified by demographic characteristics and geographic region...
January 31, 2024: Gynecologic Oncology
https://read.qxmd.com/read/38295667/decisions-and-prompts-to-screen-for-cervical-bowel-and-breast-cancer
#37
JOURNAL ARTICLE
Laura E Anderson, Katelyn E Collins, Larry Myers, Michael J Ireland, Mariam Omar, Allanah Drummond, Belinda C Goodwin
OBJECTIVES: To investigate what makes Australians decide to screen and follow through for breast, cervical, and bowel cancer population screening programs. METHODS: A convenience sample (N = 962) answered open-text questions about their decision to screen and what prompted them to act in an online survey. Open text responses were coded based on shared meaning using content analysis. Frequencies of each code were calculated. RESULTS: For breast and cervical screening, decisions were commonly based on screening being routine (32...
January 26, 2024: Patient Education and Counseling
https://read.qxmd.com/read/38295311/clinical-diagnosis-of-cervical-lesions-combined-with-programmed-death-ligand-and-mir-124-detection-in-peripheral-blood
#38
JOURNAL ARTICLE
Haixia Xu, Yan Jin, E Hu, Zhifang Huang, Bixia Yi, Fan Wang
OBJECTIVE: This study aims to analyze the expression of colposcopy combined with PD-L1 (programmed death ligand-1) and miR-124 (microRNA-124) in CC (cervical cancer) and CIN (cervical precancerous lesions), providing insights for clinical screening and diagnosis of these conditions. METHOD: A total of 60 patients with suspicious cervical lesions were selected from the gynecological clinic at Jinhua People's Hospital between June 2021 and December 2021. The patients were divided into three groups: LSIL (low-grade squamous intraepithelial lesions), HSIL (high-grade squamous intraepithelial lesions), and no SIL group, with 20 cases per group...
December 31, 2023: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38292923/external-quality-assessment-program-for-human-papillomaviruses-dna-testing-in-thailand
#39
JOURNAL ARTICLE
Pilailuk Akkapaiboon Okada, Suratchana Mitrat, Archawin Rojanawiwat
BACKGROUND: Since 2020, the National Health Security Office includes the human papillomavirus DNA testing for cervical cancer screening in the government's healthcare schemes. HPV DNA testing has become primary screening in many laboratories in Thailand. External quality assurance scheme is crucial for assessment of laboratory performance. OBJECTIVES: The aim of this study was to develop a pilot program using LBC samples for the EQA of molecular methods and to review the methods used by participants to detect the presence of high risk HPV genotypes...
January 2024: Practical Laboratory Medicine
https://read.qxmd.com/read/38286273/squamocolumnar-junction-visibility-age-and-implications-for-cervical-cancer-screening-programs
#40
JOURNAL ARTICLE
Kanan T Desai, Natasha Hansen, Ana-Cecilia Rodriguez, Brian Befano, Didem Egemen, Julia C Gage, Nicolas Wentzensen, Catya Lopez, Jose Jeronimo, Silvia de Sanjose, Mark Schiffman
Visual assessment is currently used for primary screening or triage of screen-positive individuals in cervical cancer screening programs. Most guidelines recommend screening and triage up to at least age 65 years old. We examined cervical images from participants in three National Cancer Institute funded cervical cancer screening studies: ALTS (2864 participants recruited between 1996 and 1998) in the United States (US), NHS (7548 in 1993) in Costa Rica, and the Biopsy study (684 between 2009 and 2012) in the US...
January 27, 2024: Preventive Medicine
keyword
keyword
73263
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.